?:authorAffiliation
|
-
[\'Integrative Pharmacology & Systems Neuroscience Group, IMIM (Hospital Del Mar Medical Research Institute), Barcelona, Spain; Department of Experimental & Health Sciences, Universitat Pompeu Fabra (CEXS-UPF), Barcelona, Spain.\', \'Integrative Pharmacology & Systems Neuroscience Group, IMIM (Hospital Del Mar Medical Research Institute), Barcelona, Spain; Department of Experimental & Health Sciences, Universitat Pompeu Fabra (CEXS-UPF), Barcelona, Spain; Spanish Biomedical Research Centre in Physiopathology of Obesity and Nutrition (CIBEROBN), Instituto de Salud Carlos III (ISCIII), Madrid, Spain.\', \'Integrative Pharmacology & Systems Neuroscience Group, IMIM (Hospital Del Mar Medical Research Institute), Barcelona, Spain.\', \'Critical Care Department, Hospital Del Mar, Barcelona, Spain; Critical Illness Research Group (GREPAC), IMIM (Hospital Del Mar Medical Research Institute), Barcelona, Spain; Division of Pulmonary Diseases & Critical Care Medicine, University of Texas Health San Antonio, TX, USA.\', \'Critical Care Department, Hospital Del Mar, Barcelona, Spain; Critical Illness Research Group (GREPAC), IMIM (Hospital Del Mar Medical Research Institute), Barcelona, Spain; Department of Medicine, Universitat Autònoma de Barcelona (UAB), Barcelona, Spain.\', \'Integrative Pharmacology & Systems Neuroscience Group, IMIM (Hospital Del Mar Medical Research Institute), Barcelona, Spain. Electronic address: opozo@imim.es.\']
|